Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Bone Biologics Reaches Major Preclinical Milestone In Regenerative Bone Material Development

This article was originally published in Clinica

Executive Summary

Bone Biologics is poised to reach an important milestone in its long journey to develop its NELL-1 osteoinductive protein into a commercially viable product for spine surgery. The firm plans to start large animal studies in the second half of 2016.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register